Weis Markets WMK · NYSE
$79.16 -1.41% (-$1.13)
Summary
52 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $140.0M in the last fiscal year, 7.0% of its market value.
- It could repay all its net debt from 0.1 years of operating profit.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 7.8% a year over the last 3 years.
- Out of every 100 USD of revenue, only 1.9 USD is left as net profit.
- It earns only 4.6 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 20.4 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
Revenue grew by 3.8% a year over 5 years. Over the last 3 years it grew by 1.8% a year. Earnings per share fell by 7.8% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 77 USD
- Sales and administration 21 USD
- Taxes and other 0.3 USD
- Net profit 1.9 USD
Net profit, industry median (Grocery Stores) 2.7 USD
Out of every 100 USD of revenue, 1.9 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 5.1 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.69%
- Paid out of profit
- 35%
You receive $1.36 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 50%
- Grocery 41%
- Pharmacy 6.8%
- Fuel, Product 2.5%
- Manufacturing 0.1%
By region
The company reports no revenue by region.
Product brings in 50% of revenue. Pharmacy grew fastest, by 14% a year.
Segments in detail